论著

线粒体DNA 8344 A>G突变导致的MELAS/MERRF/Leigh重叠综合征

  • 候越 ,
  • 赵旭彤 ,
  • 谢志颖 ,
  • 袁云 ,
  • 王朝霞
展开
  • 北京大学第一医院神经内科,北京 100034

收稿日期: 2018-10-12

  网络出版日期: 2020-10-15

Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes / myoclonus epilepsy with ragged-red fibers /Leigh overlap syndrome caused by mitochondrial DNA 8344A>G mutation

  • Yue HOU ,
  • Xu-tong ZHAO ,
  • Zhi-ying XIE ,
  • Yun YUAN ,
  • Zhao-xia WANG
Expand
  • Department of Neurology, Peking University First Hospital, Beijing 100034, China

Received date: 2018-10-12

  Online published: 2020-10-15

摘要

目的:线粒体DNA 8344 A>G(m.8344A>G)是肌阵挛性癫痫伴破碎红纤维(mitochondrial myoclonus epilepsy with ragged-red fibers,MERRF)综合征的常见致病突变,报道1例罕见的由m.8344A>G突变引起的线粒体脑肌病伴乳酸酸中毒和卒中样发作/肌阵挛性癫痫伴破碎红纤维/Leigh(mitochondrial encephalopathy, lactic acidosis and stroke-like episodes /MERRF/Leigh,MELAS/MERRF/Leigh)重叠综合征。方法:随访观察1例线粒体病患者,应用聚合酶链反应-限制性片段长度多态性(polymerase chain reaction-restriction fragment length polymorphism,PCR-RFLP)、高通量测序及Sanger测序对其线粒体基因进行分析。结果:患者男性,25岁,6岁后出现运动耐力差;10岁时因偏侧视野缺损行头颅磁共振成像(magnetic resonance imaging,MRI)示枕叶卒中样病灶,磁共振波谱分析(magnetic resonance spectroscopy,MRS)示病灶内乳酸峰升高;后患者认知功能逐渐减退;12岁出现行走不稳、意向性震颤,以及四肢肌阵挛发作;21岁因意识障碍入院,多次行头颅MRI示双侧壳核后部、丘脑及中脑对称性异常信号且范围逐渐扩大,并出现额叶多发卒中样病灶,经改善代谢、抗癫痫和物理康复治疗后症状逐渐好转;24岁时复查MRI示双侧基底节及丘脑异常信号范围缩小,中脑病灶消退。肌肉病理活检可见破碎红纤维(ragged-red fibers,RRF)。PCR-PFLP检测患者血液DNA发现存在m.8344A>G突变,二代测序显示其突变比例为90%,且未发现其他线粒体DNA位点致病突变。患者母亲的血液亦存在低比例m.8344A>G突变。结论:报道了m.8344A>G可导致MELAS/MERRF/Leigh重叠综合征,该例患者扩展了m.8344A>G的表型谱。

本文引用格式

候越 , 赵旭彤 , 谢志颖 , 袁云 , 王朝霞 . 线粒体DNA 8344 A>G突变导致的MELAS/MERRF/Leigh重叠综合征[J]. 北京大学学报(医学版), 2020 , 52(5) : 851 -855 . DOI: 10.19723/j.issn.1671-167X.2020.05.009

Abstract

Objective: Mitochondrial deoxyribonucleic acid (mtDNA) 8344 A>G (m.8344A>G) mutation is the common mutation associated with mitochondrial myoclonus epilepsy with ragged-red fibers (MERRF) syndrome. Herein we report a rare case with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes/MERRF/Leigh (MELAS/MERRF/Leigh) overlap syndrome caused by m.8344A>G mutation. Methods: The clinical and imaging data of the patient were collected and an open muscle biopsy was carried out. We further employed molecular genetic analyses to detect mtDNA mutation in the proband and his mother. And then a clinical and neuroimaging follow-up was performed. Results: This patient was a 25-year-old male, who developed exercise intolerance since the age of 6. At age 10, he suffered from acute episodes of hemianopia, and cranial magnetic resonance imaging (MRI) showed occipital stroke-like lesions and cranial magnetic resonance spectroscopy (MRS) revealed a lactate peak corresponding to the lesion. After that the patient presented slowly progressive psychomotor decline. He had myoclonic seizures and cerebellar ataxia since the age of 12. At age 21, he was admitted to our hospital because of confusion and cranial MRI revealed symmetrical lesions in bilateral posterior putamen, thalami and midbrain. Then repeated MRI showed progression of original lesions and new frontal multiple stroke-like lesions. Symptomatic and rehabilitation treatment relieved his condition. Follow-up cranial MRI at age 24 showed the lesions in basal ganglia and thalami diminished, and the midbrain lesions even completely vanished. Muscle pathology indicated the presence of numerous scattered ragged-red fibers (RRF), suggestive of a mitochondrial disorder. Polymerase chain reaction-restricted fragment length polymorphism (PCR-RFLP) detected the m.8344A>G mutation of the MT-TK gene encoding mitochondrial transfer RNA for lysine in the patient’s blood. Next generation sequencing (NGS) of the whole mitochondrial genome identified that the proportion of m.8344A>G was 90%, and no other mtDNA mutation was detected. Sanger sequencing further identified this mutation both in the proband and his mother’s blood, although the mutation load was much lower in his mother’s blood with approximately 10% heteroplasmy. Conclusion: The present study is the first to describe a patient with m.8344A>G mutation in association with the MELAS/MERRF/Leigh overlap syndrome, which expands the phenotypic spectrum of the m.8344A>G mutation.

参考文献

[1] Alston CL, Rocha MC, Lax NZ, et al. The genetics and pathology of mitochondrial disease[J]. J Pathol, 2017,241(2):236-250.
[2] El-Hattab AW, Adesina AM, Jones J, et al. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options[J]. Mol Genet Metab, 2015,116(1/2):4-12.
[3] Lake NJ, Compton AG, Rahman S, et al. Leigh syndrome: one disorder, more than 75 monogenic causes[J]. Ann Neurol, 2016,79(2):190-203.
[4] Bonfante E, Koenig MK, Adejumo RB, et al. The neuroimaging of Leigh syndrome: case series and review of the literature[J]. Pediatr Radiol, 2016,46(4):443-451.
[5] Liu K, Zhao H, Ji K, et al. MERRF/MELAS overlap syndrome due to the m.3291T>C mutation[J]. Metab Brain Dis, 2014,29(1):139-144.
[6] Lorenzoni PJ, Scala RH, Kay CSK, et al. When should MERRF (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis[J]. Arq Neuropsiquiatr, 2014,72(10):803-811.
[7] 陈涓涓, 陈旭辉, 陈淮菁, 等. m.10158T>C致线粒体脑肌病伴高乳酸血症和卒中样发作叠加Leigh综合征1例临床、病理及基因特点[J]. 中华神经科杂志, 2017,50(6):435-439.
[8] 韩漫夫, 白润涛, 冯宏业, 等. 线粒体DNA G13513A突变所致线粒体脑肌病伴高乳酸血症和脑卒中样发作/Leigh重叠综合征[J]. 中华神经科杂志, 2009,42(4):248-252.
[9] Yang H, Lu Q, Cui L. Symmetric thalamic lesions in a patient with a myoclonic epilepsy with ragged red fibers-Leigh spectrum phenotype due to the m.A8344G mutation[J]. Pediatr Neurol, 2014,51(6):e19-20.
[10] Monden Y, Mori M, Kuwajima M, et al. Late-onset Leigh syndrome with myoclonic epilepsy with ragged-red fibers[J]. Brain Dev, 2013,35(6):582-585.
[11] Yu N, Zhang YF, Zhang K, et al. MELAS and Kearns-Sayre overlap syndrome due to the mtDNA m. A3243G mutation and large-scale mtDNA deletions[J]. eNeurologicalSci, 2016,4:15-18.
[12] Emmanuele V, Silvers DS, Sotiriou E, et al. MERRF and Kearns-Sayre overlap syndrome due to the mitochondrial DNA m.3291T>C mutation[J]. Muscle Nerve, 2011,44(3):448-451.
[13] Zuccoli G, Yannes MP, Nardone R, et al. Bilateral symmetrical basal ganglia and thalamic lesions in children: an update (2015)[J]. Neuroradiology, 2015,57(10):973-989.
[14] 魏妍平, 崔丽英, 彭斌. ND3基因突变导致的线粒体脑肌病重叠综合征二例[J]. 脑与神经疾病杂志, 2016,24(10):626-630.
[15] Sofou K, Steneryd K, Wiklund LM, et al. MRI of the brain in childhood-onset mitochondrial disorders with central nervous system involvement[J]. Mitochondrion, 2013,13(4):364-371.
[16] Lee HF, Tsai CR, Chi CS, et al. Leigh syndrome: clinical and neuroimaging follow-up[J]. Pediatr Neurol, 2009,40(2):88-93.
[17] Nakamura M, Yabe I, Sudo A, et al. MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes[J]. J Med Genet, 2010,47(10):659-664.
[18] Craven L, Alston CL, Taylor RW, et al. Recent advances in mitochondrial disease[J]. Annu Rev Genomics Hum Genet, 2017,18:257-275.
[19] Altmann J, Buchner B, Nadaj-Pakleza A, et al. Expanded phenotypic spectrum of the m.8344A>G “MERRF” mutation: data from the German mitoNET registry[J]. J Neurol, 2016,263(5):961-972.
[20] Munoz-Malaga A, Bautista J, Salazar JA, et al. Lipomatosis, proximal myopathy, and the mitochondrial 8344 mutation. A lipid storage myopathy[J]. Muscle Nerve, 2000,23(4):538-542.
[21] Blakely EL, Alston CL, Lecky B, et al. Distal weakness with respiratory insufficiency caused by the m.8344A > G “MERRF” mutation[J]. Neuromuscul Disord, 2014,24(6):533-536.
[22] Howell N, Kubacka I, Smith R, et al. Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease[J]. Neurology, 1996,46(1):219-222.
[23] Han JY, Sung JJ, Park HK, et al. Adult onset Leigh syndrome with mitochondrial DNA 8344 A > G mutation[J]. J Clin Neurosci, 2014,21(11):2009-2011.
[24] Tsao CY, Herman G, Boue DR, et al. Leigh disease with mitochondrial DNA A8344G mutation: case report and brief review[J]. J Child Neurol, 2003,18(1):62-64.
[25] Erol I, Alehan F, Horvath R, et al. Demyelinating disease of central and peripheral nervous systems associated with a A8344G mutation in tRNALys[J]. Neuromuscul Disord, 2009,19(4):275-278.
[26] Ahmed ST, Craven L, Russell OM, et al. Diagnosis and treatment of mitochondrial myopathies[J]. Neurotherapeutics, 2018,15(4):943-953.
[27] Molnar MJ, Kovacs GG. Mitochondrial diseases[J]. Handb Clin Neurol, 2017,145:147-155.
文章导航

/